Submission Details
| 510(k) Number | K122367 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2012 |
| Decision Date | November 02, 2012 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K122367 is an FDA 510(k) clearance for the BARD PTV DILATATION CATHETER, a Pulmonary (pulmonic) Valvuloplasty Catheters/percutaneous Valvuloplasty Catheter (Class II — Special Controls, product code OMZ), submitted by C.R. Bard, Inc. (Tempe, US). The FDA issued a Cleared decision on November 2, 2012, 88 days after receiving the submission on August 6, 2012. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K122367 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2012 |
| Decision Date | November 02, 2012 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OMZ — Pulmonary (pulmonic) Valvuloplasty Catheters/percutaneous Valvuloplasty Catheter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | Catheter Is Used For Percutaneous Transluminal Or Balloon Valvuloplasty (ptv) Of The Pulmonary (pulmonic) Valve. Used On Patients With Isolated Pulmonary Stenosis And Also On Patients With Valvular Pulmonary Stenosis With Other Minor Congenital Heart Disease That Does Not Require Surgical Intervention. |